Malignancy

[1]  L. Temple,et al.  Readmissions With Dehydration After Ileostomy Creation: Rethinking Risk Factors , 2018, Diseases of the colon and rectum.

[2]  Minji K. Lee,et al.  Patient-reported outcome domains for the esophageal CONDUIT report card: a prospective trial to establish domains , 2018, Health and Quality of Life Outcomes.

[3]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[4]  F. Goldwasser,et al.  Resting energy metabolism and anticancer treatments , 2018, Current opinion in clinical nutrition and metabolic care.

[5]  Vickie Baracos,et al.  ESPEN guidelines on nutrition in cancer patients. , 2017, Clinical nutrition.

[6]  E. Horwitz,et al.  Causes of death among cancer patients , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  H. Lenz,et al.  Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment , 2016, Clinical Cancer Research.

[8]  Shishira S. Bharadwaj,et al.  Intestinal Failure: Adaptation, Rehabilitation, and Transplantation , 2016, Journal of clinical gastroenterology.

[9]  L. Pironi.  Definitions of intestinal failure and the short bowel syndrome. , 2016, Best practice & research. Clinical gastroenterology.

[10]  E. Bugianesi,et al.  Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. , 2016, Annual review of medicine.

[11]  K. S. Prabhu,et al.  The microbiome and obesity-an established risk for certain types of cancer. , 2014, Cancer journal.

[12]  C. Compher,et al.  A.S.P.E.N. clinical guidelines: Nutrition screening, assessment, and intervention in adults. , 2013, JPEN. Journal of parenteral and enteral nutrition.

[13]  A. Berry.  Pancreatic surgery: indications, complications, and implications for nutrition intervention. , 2013, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[14]  A. Asakawa,et al.  Cancer cachexia—pathophysiology and management , 2013, Journal of Gastroenterology.

[15]  D. August,et al.  Perioperative nutrition support in cancer patients. , 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[16]  C. Rock,et al.  Nutrition and physical activity guidelines for cancer survivors , 2012, CA: a cancer journal for clinicians.

[17]  A. Jemal,et al.  Cancer treatment and survivorship statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[18]  M. Markman,et al.  Role of nutritional status in predicting quality of life outcomes in cancer – a systematic review of the epidemiological literature , 2012, Nutrition Journal.

[19]  A. Figer,et al.  Effect of Tumor Load on Energy Expenditure in Patients With Pancreatic Cancer , 2012, Pancreas.

[20]  C. Rogers.  Postgastrectomy nutrition. , 2011, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[21]  D. Kuik,et al.  Perioperative arginine-supplemented nutrition in malnourished patients with head and neck cancer improves long-term survival. , 2010, The American journal of clinical nutrition.

[22]  Hae-Ra Han,et al.  The impact of glutamine dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a meta-analysis of randomized clinical trials. , 2010, JPEN. Journal of parenteral and enteral nutrition.

[23]  G. Schuler,et al.  Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training , 2010, Journal of cachexia, sarcopenia and muscle.

[24]  M. Krzystek-Korpacka,et al.  Circulating leptin and inflammatory response in esophageal cancer, esophageal cancer-related cachexia-anorexia syndrome (CAS) and non-malignant CAS of the alimentary tract. , 2010, Cytokine.

[25]  P. Marik,et al.  Immunonutrition in high-risk surgical patients: a systematic review and analysis of the literature. , 2010, JPEN. Journal of parenteral and enteral nutrition.

[26]  P. Stehle,et al.  Glutamine as indispensable nutrient in oncology: experimental and clinical evidence , 2010, European journal of nutrition.

[27]  M. Tisdale.  Cancer cachexia , 2010, Current opinion in gastroenterology.

[28]  G. Taffet,et al.  Adipokines in Patients With Cancer Anorexia and Cachexia , 2010, Journal of Investigative Medicine.

[29]  Guo-Hao Wu,et al.  Resting energy expenditure and body composition in patients with newly detected cancer. , 2010, Clinical nutrition.

[30]  R. Deberardinis,et al.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer , 2010, Oncogene.

[31]  D. August,et al.  A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. , 2009, JPEN. Journal of parenteral and enteral nutrition.

[32]  M. Tisdale.  Mechanisms of cancer cachexia. , 2009, Physiological reviews.

[33]  D. August,et al.  Nutritional Care of Cancer Patients , 2008 .

[34]  B. Tan,et al.  Cachexia: prevalence and impact in medicine , 2008, Current opinion in clinical nutrition and metabolic care.

[35]  D. Moorman,et al.  Impact of Body Mass Index on Perioperative Outcomes in Patients Undergoing Major Intra-abdominal Cancer Surgery , 2008, Annals of Surgical Oncology.

[36]  P. Ritz,et al.  Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation. , 2008, Nutrition.

[37]  P. Arner,et al.  Mechanism of increased lipolysis in cancer cachexia. , 2007, Cancer research.

[38]  P. Ravasco,et al.  Colorectal Cancer: Intrinsic Characteristics Modulate Cancer Energy Expenditure and the Risk of Cachexia , 2007, Cancer investigation.

[39]  G. Jensen.  Inflammation as the key interface of the medical and nutrition universes: a provocative examination of the future of clinical nutrition and medicine. , 2006, JPEN. Journal of parenteral and enteral nutrition.

[40]  D. Battistutta,et al.  Resting energy expenditure in patients with solid tumors undergoing anticancer therapy. , 2006, Nutrition.

[41]  S. Mcclement.  Cancer anorexia-cachexia syndrome: psychological effect on the patient and family. , 2005, Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society.

[42]  M. Tisdale.  Tumor–host interactions , 2004, Journal of cellular biochemistry.

[43]  A. Asakawa,et al.  Cancer anorexia-cachexia syndrome: cytokines and neuropeptides , 2004, Current opinion in clinical nutrition and metabolic care.

[44]  K. Fearon,et al.  Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids , 2004, British Journal of Cancer.

[45]  P. Wischmeyer,et al.  Prevention of chemotherapy and radiation toxicity with glutamine. , 2003, Cancer treatment reviews.

[46]  L. Hildebrandt,et al.  Comparison of formulaic equations to determine energy expenditure in the critically ill patient. , 2003, Nutrition.

[47]  J. R. Andersen,et al.  Incidence of nutritional risk and causes of inadequate nutritional care in hospitals. , 2002, Clinical nutrition.

[48]  M Ferguson,et al.  Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer , 2002, European Journal of Clinical Nutrition.

[49]  M. Braga,et al.  Metabolic and Functional Results After Laparoscopic Colorectal Surgery , 2002, Diseases of the colon and rectum.

[50]  M. Sitrin,et al.  Evaluation of stress factors and body weight adjustments currently used to estimate energy expenditure in hospitalized patients. , 2002, JPEN. Journal of parenteral and enteral nutrition.

[51]  M. Braga,et al.  A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. , 2002, Gastroenterology.

[52]  D. Heyland,et al.  Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. , 2001, JAMA.

[53]  Guo-Hao Wu,et al.  Modulation of postoperative immune and inflammatory response by immune-enhancing enteral diet in gastrointestinal cancer patients. , 2001, World journal of gastroenterology.

[54]  R. Negrin,et al.  Effect of oral glutamine supplementation during bone marrow transplantation. , 2000, JPEN. Journal of parenteral and enteral nutrition.

[55]  A. Frei,et al.  Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. , 1999, Archives of surgery.

[56]  M. Ferguson,et al.  Validation of a malnutrition screening tool for patients receiving radiotherapy. , 1999, Australasian radiology.

[57]  M. Ferguson,et al.  Development of a valid and reliable malnutrition screening tool for adult acute hospital patients. , 1999, Nutrition.

[58]  F. López‐Soriano,et al.  The role of cytokines in cancer cachexia , 1999, Medicinal research reviews.

[59]  P. Stehle,et al.  Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study. , 1998, Annals of surgery.

[60]  M. Heslin,et al.  A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. , 1997, Annals of surgery.

[61]  M. Braga,et al.  Gut function and immune and inflammatory responses in patients perioperatively fed with supplemented enteral formulas. , 1996, Archives of surgery.

[62]  S. Heys,et al.  Nutritional pharmacology and malignant disease: A therapeutic modality in patients with cancer , 1996, The British journal of surgery.

[63]  H. Redmond,et al.  Mechanisms mediating cancer cachexia , 1995, Cancer.

[64]  W. Willett,et al.  Diet, nutrition, and avoidable cancer. , 1995, Environmental health perspectives.

[65]  M. Elia,et al.  Measurements of resting energy expenditure and body composition before and after treatment of small cell lung cancer. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[66]  M. Tisdale,et al.  Effect of polyunsaturated fatty acids on the growth of murine colon adenocarcinomas in vitro and in vivo. , 1994, British Journal of Cancer.

[67]  J. Ross,et al.  Cytokines, the Acute‐Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic Cancer , 1994, Annals of surgery.

[68]  K. Fearon.  The mechanisms and treatment of weight loss in cancer , 1992, Proceedings of the Nutrition Society.

[69]  P. Soeters,et al.  Efficacy of perioperative nutritional support , 1992, The Lancet.

[70]  D. Bunout,et al.  Nutritional status of surgical patients and the relationship of nutrition to postoperative outcome. , 1992, Journal of the American College of Nutrition.

[71]  W. Saris,et al.  Resting energy expenditure in patients with non‐small cell lung cancer , 1991, Cancer.

[72]  T. Delozier,et al.  Polyadenylic-polyuridylic acid plus locoregional and pelvic radiotherapyversus chemotherapy with CMF as adjuvants in operable breast cancer , 1991, Breast Cancer Research and Treatment.

[73]  A. Billiau,et al.  Severe cachexia in mice inoculated with interferon‐γ‐producing tumor cells , 1991 .

[74]  T. Fahey,et al.  Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. , 1990, The Journal of clinical investigation.

[75]  L. Moldawer,et al.  Appearance of hybridoma growth factor/interleukin-6 in the serum of mice bearing a methylcholanthrene-induced sarcoma. , 1988, Biochemical and biophysical research communications.

[76]  J. H. Shaw,et al.  Fatty Acid and Glycerol Kinetics in Septic Patients and in Patients with Gastrointestinal Cancer: The Response to Glucose Infusion and Parenteral Feeding , 1987, Annals of surgery.

[77]  D. Foschi,et al.  Hyperalimentation of jaundiced patients on percutaneous transhepatic biliary drainage , 1986, The British journal of surgery.

[78]  D. Hansell,et al.  The Relationship Between Resting Energy Expenditure and Weight Loss in Benign and Malignant Disease , 1986, Annals of surgery.

[79]  I. Feurer,et al.  Energy expenditure in malnourished gastrointestinal cancer patients , 1984, Cancer.

[80]  D. Lees,et al.  Resting Energy Expenditure in Controls and Cancer Patients with Localized and Diffuse Disease , 1984, Annals of surgery.

[81]  I. Feurer,et al.  Energy Expenditure in Malnourished Cancer Patients , 1983, Annals of surgery.

[82]  T. Scherstén,et al.  Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients , 1982, Cancer.

[83]  J. Müller,et al.  PREOPERATIVE PARENTERAL FEEDING IN PATIENTS WITH GASTROINTESTINAL CARCINOMA , 1982, The Lancet.

[84]  A. Golubev,et al.  Peculiarities of hyperlipidaemia in tumour patients. , 1981, British Journal of Cancer.

[85]  Joseph R. Bertino,et al.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. , 1980, The American journal of medicine.

[86]  W. Dewys.  Anorexia as a general effect of cancer , 1979, Cancer.

[87]  G. Bodey,et al.  Causes of death in cancer patients , 1974 .

[88]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[89]  H. O. Studley.  PERCENTAGE OF WEIGHT LOSS: BASIC INDICATOR OF SURGICAL RISK IN PATIENTS WITH CHRONIC PEPTIC ULCER , 1936 .

[90]  S. Warren.  THE IMMEDIATE CAUSES OF DEATH IN CANCER , 1932 .

[91]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[92]  A. Polednak.  Estimating the number of U.S. incident cancers attributable to obesity and the impact on temporal trends in incidence rates for obesity-related cancers. , 2008, Cancer detection and prevention.

[93]  D. Wagener,et al.  Cancer cachexia demonstrates the energetic impact of gluconeogenesis in human metabolism. , 2006, Medical hypotheses.

[94]  A. Bosy-Westphal,et al.  Effect of organ and tissue masses on resting energy expenditure in underweight, normal weight and obese adults , 2004, International Journal of Obesity.

[95]  M. Braga,et al.  Artificial nutrition after major abdominal surgery: impact of route of administration and composition of the diet. , 1998, Critical care medicine.

[96]  C. Garcı́a-Martı́nez,et al.  Is TNF really involved in cachexia? , 1997, Cancer investigation.

[97]  F. Ottery,et al.  Definition of standardized nutritional assessment and interventional pathways in oncology. , 1996, Nutrition.

[98]  Identifying patients at risk: ADA's definitions for nutrition screening and nutrition assessment. Council on Practice (COP) Quality Management Committee. , 1994, Journal of the American Dietetic Association.

[99]  K. Lundholm,et al.  Elevated energy expenditure in cancer patients with solid tumours. , 1991, European journal of cancer.

[100]  J. Norton,et al.  Cancer cachexia. , 1988, JPEN. Journal of parenteral and enteral nutrition.

[101]  A S Detsky,et al.  What is subjective global assessment of nutritional status? , 1987, JPEN. Journal of parenteral and enteral nutrition.

[102]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.